4//SEC Filing
Mattes Glenn R. 4
Accession 0001213900-22-027791
CIK 0001733413other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 9:51 PM ET
Size
5.8 KB
Accession
0001213900-22-027791
Insider Transaction Report
Form 4
Mattes Glenn R.
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2022-05-16$4.78/sh+16,000$76,480→ 36,000 total
Holdings
- 7,000(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]The reported shares were purchased in the open market in multiple transactions at prices ranging from $4.32 to $4.95. The price reported in Column 4 is a weighted average price. The reporting person undertakes to provide to TFF Pharmaceuticals, Inc., any stockholder of TFF Pharmaceuticals, Inc or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001568678
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 9:51 PM ET
- Size
- 5.8 KB